Arformoterol Tartrate Inhalation Solution
Product Images NDC 73043-052

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate Inhalation (NDC 73043-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Image (Carton)

Carton Image (Carton)
The packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Devatis, Inc. It includes details for 60 unit-dose vials, with instructions to keep refrigerated or store at room temperature for up to 6 weeks. The label notes that it is for oral inhalation only and prescription use (Rx Only). Barcode and regulatory information are also present.*
FDA Label Image

Image (Figure 1)

Image (Figure 1)
A line graph depicting mean change from baseline FEV1 (Liters) over 12 hours postdose, comparing arformoterol tartrate inhalation solution 15 mcg BID with placebo. The arformoterol group shows a rapid increase peaking around 1 hour and sustained above baseline, while placebo remains near baseline throughout the period.*
FDA Label Image

Image (Figure 2)

Image (Figure 2)
A line graph showing mean change from baseline FEV1 (in liters) over 12 hours postdose for Arformoterol Tartrate Inhalation solution 15 mcg versus placebo. The x-axis represents hours postdose, and the y-axis shows the mean change in FEV1. Two lines compare treatment and placebo groups, with data points plotted for each hour.*
FDA Label Image

Patient Information Figure 1 (Patient 1)

Patient Information Figure 1 (Patient 1)
An instructional illustration showing a hand holding a small inhalation vial or ampule. An arrow indicates a twisting or turning motion of the vial's top, suggesting how to open or activate the inhalation solution device.*
FDA Label Image

Patient Information Figure 2 (Patient 2)

Patient Information Figure 2 (Patient 2)
An instructional diagram showing a hand inserting or placing a component, possibly a cartridge or part of a device, into a labeled reservoir. The image is black and white with clear labels and outlines, likely demonstrating assembly or usage steps for a respiratory inhalation device.*
FDA Label Image

Patient Information Figure 3 (Patient 3)

Patient Information Figure 3 (Patient 3)
An instructional diagram showing an inhalation device with its mouthpiece labeled. The image highlights the mouthpiece component of the Arformoterol Tartrate Inhalation delivery device.*
FDA Label Image

Patient Information Figure 4 (Patient 4)

Patient Information Figure 4 (Patient 4)
An instructional illustration showing a face mask intended for use with an inhalation device, depicting the mask connected to the device. The image emphasizes the face mask component for respiratory drug administration.*
FDA Label Image

Patient Information Figure 5 (Patient 5)

Patient Information Figure 5 (Patient 5)
An illustration showing a medical device labeled 'COMPRESSOR' with a control knob and meter display, connected to tubing. The tubing is attached to the compressor's front panel, indicating a component of a respiratory inhalation system, likely related to nebulizer use.*
FDA Label Image

Patient Information Figure 6 (Patient 6)

Patient Information Figure 6 (Patient 6)
An instructional illustration showing a person using a respiratory inhalation device, with the mouth placed on the inhaler mouthpiece and the inhaler held in hand.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Arformoterol Tartrate shown as two connected molecular diagrams depicting the active ingredient in inhalation solution form.*
FDA Label Image

Ampule Label (Tail)

Ampule Label (Tail)
Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, sterile. The label includes the proprietary and nonproprietary name, strength, dosage form, and the Devatis, Inc. logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.